News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HemCon Medical Technologies, Inc. Signs Exclusive Partnership for the Development and Distribution of Synaero(TM) Hemostatic Gel for ENT Procedures


9/23/2010 10:19:15 AM

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies (“HemCon”), a global innovative developer of advanced medical technologies and products, has recently partnered with ENTrigue Surgical, Inc. (“ENTrigue”), a leading provider of medical devices and therapies for surgeries of the Ear, Nose and Throat, to develop and distribute HemCon’s latest breakthrough product, a hemostatic surgical gel. Synaero Hemostatic Gel, based on HemCon’s proprietary oxidized cellulose platform, is a hemostatic gel to be used during and after ENT surgical procedures to control bleeding, minimize edema and prevent adhesions.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES